In this study, we established the first in vitro muscle model for PGM1-linked myopathy via genome editing to investigate the muscle-specific role of PGM1 and the effects of D-galactose on myogenic differentiation, nucleotide sugar metabolism, and energy homeostasis. Here, PGM1 is linked to myopathy.